Adrenomedullin Versus BNP as Heart Function Markers in Dialysis Patients
Both mature adrenomedullin and BNP correlated with cardiac function in hemodialysis patients, but BNP was more closely tied to LV dysfunction while adrenomedullin reflected broader cardiovascular and renal status.
Quick Facts
What This Study Found
Mature adrenomedullin and BNP provided complementary cardiac information in hemodialysis patients: BNP reflected LV dysfunction more specifically, while mAM reflected broader cardiovascular status including vascular and renal components.
Key Numbers
How They Did This
Cross-sectional study in hemodialysis patients comparing mature adrenomedullin, ANP, and BNP with echocardiographic cardiac function parameters.
Why This Research Matters
Dialysis patients have extremely high cardiovascular mortality. Using complementary biomarkers (BNP for heart, mAM for heart + vessels) could improve cardiovascular risk assessment in this high-risk population.
The Bigger Picture
Different biomarkers reveal different disease mechanisms. Multi-marker approaches combining cardiac-specific (BNP) and cardiovascular-broad (ADM) peptides provide a more complete risk picture.
What This Study Doesn't Tell Us
Cross-sectional in hemodialysis patients. Dialysis timing affects peptide levels. Specific mAM assay may vary between studies.
Questions This Raises
- ?Should both BNP and mAM be monitored in dialysis patients?
- ?Does mAM predict vascular events independently of BNP?
- ?Can multi-marker panels improve dialysis patient survival?
Trust & Context
- Key Stat:
- Complementary markers BNP reflects heart dysfunction specifically; adrenomedullin reflects heart + vessel + kidney status — together they provide more complete risk assessment
- Evidence Grade:
- Moderate evidence from a comparative biomarker study in a clinically relevant high-risk population.
- Study Age:
- Published in 2002. Both BNP/NT-proBNP and MR-proADM are now used clinically in various cardiovascular settings.
- Original Title:
- Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
- Published In:
- Nephron, 92(4), 832-9 (2002)
- Authors:
- Osajima, Akihiko, Okazaki, Masahiro, Tamura, Masahito, Anai, Hirofumi, Kabashima, Narutoshi, Suda, Takeshi, Iwamoto, Masako, Ota, Takayuki, Watanabe, Yuujiro, Kanegae, Kaori, Nakashima, Yasuhide
- Database ID:
- RPEP-00755
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Why test multiple biomarkers?
Each tells a different story. BNP specifically reflects heart muscle stress, while adrenomedullin reflects the overall cardiovascular and kidney health. Together, they give doctors a more complete picture than either alone.
Why is this important for dialysis patients?
More than half of dialysis patients die from cardiovascular disease. Better biomarker assessment identifies the highest-risk patients for targeted interventions that could save lives.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00755APA
Osajima, Akihiko; Okazaki, Masahiro; Tamura, Masahito; Anai, Hirofumi; Kabashima, Narutoshi; Suda, Takeshi; Iwamoto, Masako; Ota, Takayuki; Watanabe, Yuujiro; Kanegae, Kaori; Nakashima, Yasuhide. (2002). Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.. Nephron, 92(4), 832-9.
MLA
Osajima, Akihiko, et al. "Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.." Nephron, 2002.
RethinkPeptides
RethinkPeptides Research Database. "Comparison of plasma levels of mature adrenomedullin and nat..." RPEP-00755. Retrieved from https://rethinkpeptides.com/research/osajima-2002-comparison-of-plasma-levels
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.